American Century Companies Inc. reduced its stake in shares of Steris PLC (NYSE:STE) by 22.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 942,250 shares of the medical equipment provider’s stock after selling 271,996 shares during the quarter. American Century Companies Inc. owned approximately 1.11% of Steris worth $107,793,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of STE. Steward Partners Investment Advisory LLC increased its position in Steris by 118.0% during the 3rd quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock valued at $104,000 after purchasing an additional 492 shares during the period. First Hawaiian Bank purchased a new position in Steris during the 3rd quarter valued at $106,000. Point72 Hong Kong Ltd purchased a new position in Steris during the 2nd quarter valued at $116,000. Fort L.P. purchased a new position in Steris during the 2nd quarter valued at $121,000. Finally, Parallel Advisors LLC increased its position in Steris by 480.4% during the 3rd quarter. Parallel Advisors LLC now owns 1,364 shares of the medical equipment provider’s stock valued at $156,000 after purchasing an additional 1,129 shares during the period. 89.52% of the stock is currently owned by institutional investors and hedge funds.

In related news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $120.50, for a total transaction of $1,205,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michael J. Tokich sold 34,500 shares of the stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $119.16, for a total transaction of $4,111,020.00. Following the sale, the insider now directly owns 64,958 shares in the company, valued at $7,740,395.28. The disclosure for this sale can be found here. Insiders sold a total of 45,800 shares of company stock worth $5,464,727 over the last ninety days. Insiders own 2.38% of the company’s stock.

STE has been the topic of a number of research analyst reports. Stephens reissued a “buy” rating and set a $125.00 price objective on shares of Steris in a research report on Thursday, August 9th. Zacks Investment Research raised shares of Steris from a “sell” rating to a “hold” rating in a research report on Tuesday, October 9th. JMP Securities upped their target price on shares of Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research report on Thursday, August 9th. Finally, KeyCorp upped their target price on shares of Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 9th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Steris has a consensus rating of “Buy” and an average target price of $115.00.

NYSE:STE opened at $120.35 on Friday. The stock has a market capitalization of $10.13 billion, a PE ratio of 29.00 and a beta of 1.03. The company has a current ratio of 2.63, a quick ratio of 2.02 and a debt-to-equity ratio of 0.41. Steris PLC has a 1-year low of $82.88 and a 1-year high of $121.67.

Steris (NYSE:STE) last released its earnings results on Tuesday, November 6th. The medical equipment provider reported $1.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. The firm had revenue of $679.00 million for the quarter, compared to the consensus estimate of $659.14 million. Steris had a net margin of 11.72% and a return on equity of 12.15%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.94 EPS. On average, analysts forecast that Steris PLC will post 4.74 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Steris PLC (STE) Shares Sold by American Century Companies Inc.” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://theolympiareport.com/2018/11/11/steris-plc-ste-shares-sold-by-american-century-companies-inc.html.

About Steris

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: Growth Stocks, What They Are, What They Are Not

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.